Reading other blogs, I found a note recapping an item I read in the newspaper but put out of mind as ridiculous. But apparently it's serious. One of th major drug companies has made a compound which they've submitted to the FDA for approval -- which they expect to get -- to sell a compound that will make eye lashes grow longer and more luxuriously. This is not a oosmetic company but a serious drug company. They apparently conjecture that they could make as much as $500,000,000 in a year selling this compound (which is to be applied only to the upper lashes) -- it makes hair follicles hyperactive, it seems.
There is no disease cuasing people not to have eyelashes. It seems to be a formula targeted at all the millions of mascara and false eyelash wearers who simply want longer lashes for the sake of vanity. The question is WHY? Why did a serious drug company spend R&D money on this formula? Was it an incidental discover in attempts to find something more beneficial? Nothing I read answered that question.
There are many serious diseases that affect relatively small numbers of people -- I think that might mean less than a one person per million. In Big Phrama parlance these are called "Orphan Diseases" because the possibility of large profits from a drug aimed at those diseases may not be enough to pay back the R&D costs. Some drug companies, nevertheless DO try to formulate drugs for at least some orphan diseases and do a great service to quite a few needy individuals.
Do people lose their eyelashes as they lose hair when they have certain kinds of chemo therapy? Wouldn't they need hair growth compounds more? I can think of no NEED for most people to grow longer, lusher eyelashes. If any reader has a contrary view, I'd LOVE to hear from you.
Laurie Kuntz writes - *Peonies and Peacocks* After a painting by Maruyama Okyo (1733-95) painted in 1777 during the Edo Period In Japan, spring peonies bloom and girls learn...
1 hour ago